Open Access
Med Sci (Paris)
Volume 38, Number 5, Mai 2022
Page(s) 422 - 424
Section Le Magazine
Published online 24 May 2022
  1. de Thé G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature 1978 ; 274 : 756–761. [CrossRef] [PubMed] [Google Scholar]
  2. Ascherio A, Munger KL. EBV and Autoimmunity. Curr Top Microbiol Immunol 2015 ; 390 : 365–385. [PubMed] [Google Scholar]
  3. Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 2022; 375 : 296–301. [CrossRef] [PubMed] [Google Scholar]
  4. Lanz TV, Brewer RC, Ho PP, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 2022; 603 : 321–7. [CrossRef] [PubMed] [Google Scholar]
  5. Münz C. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis. Nat Rev Microbiol 2019 ; 17 : 691–700. [CrossRef] [PubMed] [Google Scholar]
  6. Nielsen TR, Rostgaard K, Askling J, et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler 2009 ; 15 : 431–436. [CrossRef] [PubMed] [Google Scholar]
  7. Zdimerova H, Murer A, Engelmann C, et al. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15. Eur J Immunol 2021; 51 : 64–75. [CrossRef] [PubMed] [Google Scholar]
  8. Tzartos JS, Khan G, Vossenkamper A, et al. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology 2012 ; 78 : 15–23. [CrossRef] [PubMed] [Google Scholar]
  9. Veroni C, Aloisi F. The CD8 T cell-Epstein-Barr virus-B cell trialogue: A central issue in multiple sclerosis pathogenesis. Front Immunol 2021; 12 : 665718. [CrossRef] [PubMed] [Google Scholar]
  10. Pender MP, Csurhes PA, Smith C, et al. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Mult Scler 2014 ; 20 : 1541–1544. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.